Adetunji T. Toriola, MD, PhD, MPH

Dr. Toriola is a molecular cancer epidemiologist and an associate professor of surgery in the Division of Public Health Sciences, Department of Surgery. He trained as a physician and afterwards had further training in public health and epidemiology, with emphasis on cancer epidemiology and prevention. Toriola’s research focuses on characterizing the molecular basis and determinants of mammographic breast density that are targetable, especially in premenopausal women, and to translate study findings to breast cancer prevention, through clinical trials. He is the principal investigator on a National Institutes of Health/National Cancer Institute-funded phase III clinical trial investigating the effect of RANKL inhibition on mammographic breast density and breast tissue/blood markers in high-risk premenopausal women with dense breasts (R37CA235602). In addition, he conducts molecular epidemiologic studies on gastrointestinal cancers (colorectal and pancreatic cancers), evaluating the use of biomarkers to investigate the associations of energetics, hormones and inflammation with cancer risk/mortality. He is especially interested in the interplay between inflammation and insulin resistance in colorectal and pancreatic cancer risk/mortality and the translational importance. His studies have demonstrated the robustness of combining inflammatory biomarkers into a score to improve their ability to predict cancer risk and mortality.

Toriola serves as the deputy co-director for the master’s of population health sciences (MPHS) program in the Division of Public Health Sciences.